The importance of education in patients with metabolic syndrome with regard to their knowledge and attitudes about the disease, and the impact of education on laboratory parameters
Aim A metabolic syndrome (MetS) increases the risk of heart disease and diabetes mellitus type 2, thus the aim of this study is to correlate the clinical and laboratory parameters in patients suffering from MetS who have previously had education compared to patients who have not had any education about a healthy lifestyle, and to check their knowledge and attitudes about healthy lifestyle. Methods The study included patients of both genders aged 18 - 70 years, diagnosed with MetS, who are members of the Association of Diabetics in Canton of Sarajevo. It used anthropometric parameters, laboratory findings, and an original, structured questionnaire about diet and frequency of physical activities. Results Clinical and laboratory parameters did not differ significantly between educated and uneducated patients, as well as habits in diet, physical activity, and knowledge about metabolic syndrome. The questions from the questionnaire have shown a good value of variance, suggesting that the questionnaire can be considered reliable. Conclusion This study showed that people with metabolic syndrome are not educated and motivated enough to change their lifestyle. The need for education of such patients is necessary.
Van Der Pal K, Koopman A, Lakerveld J, Van Der Heijden A, Elders P, Beulens J, et al. The association between multiple sleep-related characteristics and the metabolic syndrome in the general population: the New Hoorn study. Sleep Med. 2018. p. 51–7.
2.
Ford E. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005. p. 2745–9.
3.
Sigit F, Tahapary D, Trompet S, Sartono E, Van Dijk W, Rosendaal K, et al. The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of two population-based studies. Diabetol Metab Syndr. 2020. p. 2.
4.
Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills A, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health. 2017. p. 101.
5.
Rochlani Y, Pothineni N, Kovelamudi S, Mehta J. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017. p. 215–25.
6.
Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb. 2011. p. 629–39.
7.
Chen S, Zhao X, Ran L, Wang W, Qin X, Shu Y, et al. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig Liver Dis. 2015. p. 226–32.
8.
Kwon H, Kim D, Kim J. Body fat distribution and the risk of incident metabolic syndrome: a longitudinal cohort study. Sci Rep. 2017. p. 1–8.
9.
Goh V, Hart W. Excess fat in the abdomen but not general obesity is associated with poorer metabolic and cardiovascular health in premenopausal and postmenopausal Asian women. Maturitas. 2018. p. 33–8.
10.
Klimova B, Kuca K, Maresova P. Global view on Alzheimer’s disease and diabetes mellitus: threats, risks and treatment Alzheimer’s disease and diabetes mellitus. Curr Alzheimer Res. 2018. p. 1277–82.
11.
Chiarelli F, Mohn A. Early diagnosis of metabolic syndrome in children. Lancet Child Adolesc Health. 2017. p. 86–8.
12.
Jung J, Oh C, Choi J, Ryoo J, Chung P, Hong H, et al. Levels of systolic and diastolic blood pressure and their relation to incident metabolic syndrome. Cardiology. 2019. p. 224–31.
13.
Jung J, Oh C, Ryoo J, Choi J, Choi Y, Ham W, et al. The influence of prehypertension, hypertension, and glycated hemoglobin on the development of type 2 diabetes mellitus in prediabetes: the Korean Genome and Epidemiology Study (KoGES). Endocrine. 2018. p. 593–601.
14.
Cordero P, Li J, Oben J. Bariatric surgery as a treatment for metabolic syndrome. J R Coll Physicians Edinb. 2017. p. 364–8.
15.
Sullivan G, Artino A. Analyzing and interpreting data from likert-type scales. J Grad Med Educ. 2013. p. 541–2.
16.
Jiang B, Zheng Y, Chen Y, Chen Y, Li Q, Zhu C, et al. Age and gender-specific distribution of metabolic syndrome components in East China: role of hypertriglyceridemia in the SPECT-China study. Lipids Health Dis. 2018. p. 92.
17.
Stephens C, Easton J, Robles-Cabrera A, Fossion R, De La Cruz L, Martínez-Tapia R, et al. The impact of education and age on metabolic disorders. Front Public Health. 2020. p. 180.
18.
Fisher E, Brzezinski R, Ehrenwald M, Shapira I, Zeltser D, Berliner S, et al. Increase of body mass index and waist circumference predicts development of metabolic syndrome criteria in apparently healthy individuals with 2 and 5 years follow-up. Int J Obes (Lond). 2019. p. 800–7.
19.
Gierach M, Gierach J, Ewertowska M, Arndt A, Junik R. Correlation between body mass index and waist circumference in patients with metabolic syndrome. ISRN Endocrinology. 2014. p. 514589.
20.
Vemuri S, Desai K, Neha C, Reddy S. A questionnaire study on knowledge and awareness of metabolic syndrome and it’s components in undergraduate medical students at entry level. Res Pharm Sci. 2020. p. 3645–56.
21.
Wang Q, Chair S, Wong EL, Re TP, Qiu X, Li X. Metabolic syndrome knowledge among adults with cardiometabolic risk factors: a cross-sectional study. Int J Environ Res Public Health. 2019. p. 159.
22.
Lo S, Chair S, Lee I. Knowledge of metabolic syndrome in Chinese adults: implications for health education. Health Educ J. 2015. p. 589–99.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
